Showing 2461-2470 of 4063 results for "".
- Glaukos to Showcase Technologies at 2024 AAO Annual Meeting in Chicagohttps://modernod.com/news/glaukos-to-showcase-technologies-at-2024-aao-annual-meeting-in-chicago/2482483/Glaukos announced that its technologies will be featured in various scientific programming at the American Academy of Ophthalmology (AAO) annual meeting, October 18-21, 2024, in Chicago. Glaukos is also sponsoring an educational symposium in conjunction with EyeWorld and AAO entitl
- Clearside Biomedical Reports Positive Results from Phase 2b ODYSSEY Trial of CLS-AX for Wet AMDhttps://modernod.com/news/clearside-biomedical-reports-positive-results-from-phase-2b-odyssey-trial-of-cls-ax-for-wet-amd/2482475/Clearside Biomedical announced that its phase 2b ODYSSEY trial of CLS-AX (axitinib injectable suspension) for the treatment of wet age-related macular degeneration (AMD) achieved its primary and all secondary endpoints. In the trial, patients treated with suprachoroidal CLS-AX show
- Aviceda Completes Enrollment for Phase 2b SIGLEC Study for Geographic Atrophy Treatmenthttps://modernod.com/news/aviceda-completes-enrollment-for-phase-2b-siglec-study-for-geographic-atrophy-treatment/2482456/Aviceda Therapeutics announced the completion of patient enrollment for its phase 2b SIGLEC study. The trial is comparing the safety and efficacy of the company's lead candidate, AVD-104, with avacincaptad pegol (marketed as Izervay) for the treatment of geographic atrophy (GA) secondary to a
- Zeiss to Showcase 3D Visualization and AI Innovations at Euretina 2024https://modernod.com/news/zeiss-to-showcase-3d-visualization-and-ai-innovations-at-euretina-2024/2482438/Zeiss Medical Technology will unveil its latest digital innovations, including advanced 3D visualization technology, as part of the Zeiss Retina Workflow at the upcoming European Society of Retina Specialists (EURETINA) conference, September 19-22, 2024, in Barcelona. Among the inn
- ViaLase to Present Glaucoma Treatment Data at ESCRS 2024 in Barcelonahttps://modernod.com/news/vialase-to-present-glaucoma-treatment-data-at-escrs-2024-in-barcelona/2482423/ViaLase will present clinical data and provide an overview of its business and technology during the 42nd Congress of the European Society of Cataract and Refractive Surgeons (ESCRS), September 6-10, 2024, in Barcelona, Spain. ViaLase will be exhibiting at the Teleon Surgical booth (Boo
- 2024 Kavli Prize in Neuroscience Awarded for the Discovery of 'Face Areas' in the Brainhttps://modernod.com/news/2024-kavli-prize-in-neuroscience-awarded-for-the-discovery-of-face-areas-in-the-brain/2482322/The 2024 Kavli Prize in Neuroscience honors Nancy Kanwisher, PhD, (Massachusetts Institute of Technology); Doris Ying Tsao, PhD (University of California, Berkeley); and Winrich Freiwald, Ph.D. (Rockefeller University) for the discovery of a specialized system within the brain to r
- Alcon to Acquire Israel-Based Belkin Vision, Maker of Eagle SLT Laserhttps://modernod.com/news/alcon-to-acquire-israel-based-belkin-vision-maker-of-eagle-slt-laser/2482270/Alcon has bolstered its glaucoma surgical portfolio after announcing plans to acquire Belkin Vision in deal potentially worth more than $300 million. The deal, which was first reported by Israel-based business news provider, Globes, has been confirmed by Eyewire+. According
- Qlaris Bio Completes $24 Million Series B Financing Round to Advance IOP-lowering Drug Candidate for Glaucomahttps://modernod.com/news/qlaris-bio-completes-24-million-series-b-financing-round-to-advance-iop-lowering-drug-candidate-for-glaucoma/2482252/Qlaris Bio announced it has closed a $24 million Series B financing round to support the continued clinical development of QLS‑111, a first-in-class therapeutic being developed to lower IOP by targeting episcleral venous pressure (EVP). Qlaris is currently conducting two US ph
- Prevent Blindness Announces Recipients of the 2024 Jenny Pomeroy Award and the Rising Visionary Awardhttps://modernod.com/news/prevent-blindness-announces-recipients-of-the-2024-jenny-pomeroy-award-and-the-rising-visionary-award/2482251/Prevent Blindness named Mission for Vision (MFV) the recipient of the 2024 Jenny Pomeroy Award for Excellence in Vision and Public Health; and Erica Shelton, OD, MS, FAAO, Clinical Instructor and PhD Candidate, The Ohio State University College of Optometry, has been named as the r
- Registration Now Open for Neuro-Optometric Rehabilitation Association 2024 Conferencehttps://modernod.com/news/registration-now-open-for-neuro-optometric-rehabilitation-association-association-2024-conference/2482187/Registration is now open for the Neuro-Optometric Rehabilitation Association, International (NORA) 34th annual conference, September 19-22, at the Embassy Suites by Hilton Orlando, Lake Buena Vista South in Kissimmee, Florida. The NORA annual conference is a premier event for eye care a